Focal therapy, a non-invasive treatment which targets cancerous cells while avoiding damaging surrounding tissue, was ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

The NanoKnife system employs non-thermal IRE ablation to destroy tumour cells while preserving surrounding anatomy.

A new partnership will create a theranostics health care platform in the region with radiopharmaceutical production and therapy, molecular imaging, and clinical trials all at the same location. One ...

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1 ...

AngioDynamics, Inc. announced expanded European indications for its NanoKnife system with irreversible electroporation (IRE) ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

Researchers at Norwegian University of Science and Technology are developing an artificial intelligence tool to detect prostate cancer. Early trials show promising results, suggesting faster, more ...